[go: up one dir, main page]

PE20141179A1 - Una composicion antiparasitaria y metodo de tratamiento - Google Patents

Una composicion antiparasitaria y metodo de tratamiento

Info

Publication number
PE20141179A1
PE20141179A1 PE2013002835A PE2013002835A PE20141179A1 PE 20141179 A1 PE20141179 A1 PE 20141179A1 PE 2013002835 A PE2013002835 A PE 2013002835A PE 2013002835 A PE2013002835 A PE 2013002835A PE 20141179 A1 PE20141179 A1 PE 20141179A1
Authority
PE
Peru
Prior art keywords
treatment
composition
antiparasitic composition
alcohol
agent
Prior art date
Application number
PE2013002835A
Other languages
English (en)
Inventor
Wayne Frederick Leech
Fadil Al Alawi
Karthigeyan Nanjan
Original Assignee
Bayer New Zealand Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer New Zealand Ltd filed Critical Bayer New Zealand Ltd
Publication of PE20141179A1 publication Critical patent/PE20141179A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N57/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
    • A01N57/10—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds
    • A01N57/16—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds containing heterocyclic radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Agronomy & Crop Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

SE REFIERE A UNA COMPOSICION SOLUBILIZADA ANTIPARASITARIA VETERINARIA QUE INCLUYE: UNA LACTONA MACROCICLICA, LEVAMISOL EN LAS FORMAS DE HIDROCLORURO O FOSFATO, EDTA DISODICO COMO AGENTE QUELANTE, UN ANTIOXIDANTE, ALCOHOL BENCILICO COMO CONSERVANTE, GLICERINA FORMALDEHIDO COMO ESTABILIZADOR, POLISORBATO 80 COMO AGENTE TENSIOACTIVO. DICHA COMPOSICION PRESENTA UN RANGO DE PH DE 2,0-5,0.
PE2013002835A 2011-06-23 2012-06-22 Una composicion antiparasitaria y metodo de tratamiento PE20141179A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ59371311 2011-06-23

Publications (1)

Publication Number Publication Date
PE20141179A1 true PE20141179A1 (es) 2014-10-11

Family

ID=47422791

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2013002835A PE20141179A1 (es) 2011-06-23 2012-06-22 Una composicion antiparasitaria y metodo de tratamiento

Country Status (20)

Country Link
US (1) US9198430B2 (es)
EP (1) EP2723335A4 (es)
JP (1) JP6120834B2 (es)
KR (1) KR20140047617A (es)
CN (1) CN103717218B (es)
AU (1) AU2012273538B2 (es)
BR (1) BR112013032567B1 (es)
CA (1) CA2839491A1 (es)
CL (1) CL2013003501A1 (es)
CO (1) CO6842017A2 (es)
CR (1) CR20130642A (es)
DO (1) DOP2013000289A (es)
IL (1) IL230074A (es)
MX (1) MX355769B (es)
NI (1) NI201300139A (es)
PE (1) PE20141179A1 (es)
PH (1) PH12013502521A1 (es)
RU (1) RU2591082C2 (es)
UA (1) UA113179C2 (es)
WO (1) WO2012177151A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014031083B1 (pt) * 2012-07-17 2021-06-15 Bayer New Zealand Limited Composição farmacêutica veterinária não aquosa injetável, seringa contendo a referida composição e método de fabricação da mesma
WO2015064680A1 (ja) * 2013-10-30 2015-05-07 大蔵製薬株式会社 服用し易いゼリー状医薬組成物
US11872208B2 (en) * 2017-11-23 2024-01-16 Ceva Sante Animale Composition for treating parasites infestations

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773422A (en) * 1996-01-29 1998-06-30 Komer; Gene Avermectin formulation
NZ508969A (en) 1999-06-04 2002-12-20 Nufarm Ltd Pesticidal emulsion containing levamisole in the aqueous phase and a macrocyclic lactone anthelmintic in the organic phase
AR035550A1 (es) 1999-06-04 2004-06-16 Nufarm Ltd Composiciones estables biocidas
CN1375293A (zh) 2001-03-16 2002-10-23 王玉万 含碘醚柳胺的复方注射用驱虫药
NZ520295A (en) * 2002-07-19 2005-04-29 Ashmont Holdings Ltd Anthelmintic formulations comprising levamisole and either an avermectin or milbemycin
AU2003900505A0 (en) 2003-02-05 2003-02-20 Jurox Pty Ltd Anthelmintic composition
US7645459B2 (en) * 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of bisphosphonates
BRPI0506279B1 (pt) 2005-12-16 2018-01-09 Npa - Núcleo De Pesquisas Aplicadas Ltda Composição sinergística de antihelmínticos e endectocidas
NZ552040A (en) 2006-12-13 2009-04-30 Bomac Research Ltd Veterinary formulation comprising an anthelmintic compound and glyceryl acetate
NZ552293A (en) 2006-12-21 2009-03-31 Bomac Research Ltd Tablet formulation comprising a macrocyclic lactone and a levamisole compound having anthelmintic activity
WO2010021555A1 (en) * 2008-08-18 2010-02-25 Schering-Plough Animal Health Limited Anthelmintic compositions
AU2010201490C1 (en) * 2009-04-15 2014-07-24 Zoetis Services Llc Anthelmintic formulation
NZ570591A (en) 2009-08-18 2012-01-12 Intervet Int Bv Anthelmintic compositions
HUE028600T2 (en) 2010-05-12 2016-12-28 Merial Inc Injectable parasiticidal formulations of levamisole and macrocyclic lactones

Also Published As

Publication number Publication date
CR20130642A (es) 2014-02-19
MX355769B (es) 2018-04-30
CA2839491A1 (en) 2012-12-27
BR112013032567B1 (pt) 2020-04-28
KR20140047617A (ko) 2014-04-22
RU2014101995A (ru) 2015-07-27
EP2723335A1 (en) 2014-04-30
PH12013502521A1 (en) 2014-01-20
CN103717218B (zh) 2017-09-12
CL2013003501A1 (es) 2014-06-27
BR112013032567A2 (pt) 2017-01-24
JP2014517066A (ja) 2014-07-17
CN103717218A (zh) 2014-04-09
NI201300139A (es) 2014-02-26
UA113179C2 (xx) 2016-12-26
CO6842017A2 (es) 2014-01-20
EP2723335A4 (en) 2015-01-07
US20140221299A1 (en) 2014-08-07
DOP2013000289A (es) 2014-03-16
MX2013014460A (es) 2014-04-14
AU2012273538A1 (en) 2013-05-02
IL230074A (en) 2016-10-31
US9198430B2 (en) 2015-12-01
JP6120834B2 (ja) 2017-04-26
WO2012177151A1 (en) 2012-12-27
RU2591082C2 (ru) 2016-07-10
AU2012273538B2 (en) 2015-11-19

Similar Documents

Publication Publication Date Title
MX383908B (es) Formulaciones desinfectantes tópicas y uso de las mismas.
TN2013000310A1 (en) Effervescent composition in solid form for use in vaginal applications for the treatment of vaginal infections
GT201200276A (es) Combinaciones de compuestos activos
EP4230264A3 (en) Prodrugs of fumarates and their use in treating various deseases
CR20150422A (es) Formas de metilo {4,6-diamino-2-[1- (2-fluorobencil) -1h-pirazolo [3,4-b] piridino -3-il] pirimidino-5-il} carbamato de metilo
CU24349B1 (es) Composiciones que comprenden 2,3-dihidroimidazo [1,2-c] quinazolinas sustituidas útiles para el tratamiento del cáncer
CR20160433A (es) Nuevos compuestos
IN2014DN07483A (es)
CL2017001964A1 (es) Encapsulado de agentes activos de alta potencia.
CR20160235A (es) Tienopirimidinas como inhibidores mknk1 y mknk2
BR112017013498B8 (pt) Formulação agrícola, seu método de preparação, e composição agrícola aquosa
BR112015026193B8 (pt) Composição farmacêutica, método para formular uma composição farmacêutica, uso da composição farmacêutica, método para inibir a formação de biofilme em uma superfície, e, artigo fabricado para curativo
MX2018007992A (es) Producto para el cuidado bucal y metodos para uso y fabricacion de este.
PE20141179A1 (es) Una composicion antiparasitaria y metodo de tratamiento
MX373305B (es) Método para estabilizar una composición que contiene al menos un producto de deshidratación interna de un azúcar hidrogenado, composición resultante y usos de esta.
CO6410307A2 (es) Formulación de doramectina en dosis elevada
ES2722323T3 (es) Composición fertilizante que incluye un inhibidor de la actividad de la ureasa
UY37444A (es) Derivados sustituidos de 6-(1h-pirazol-1-il)pirimidin-4-amina y su uso
MX2017003609A (es) Inhibidor de corrosion biologica para metales.
MY180113A (en) Use of patchouli extract in the preparation of compositions with an anti-microorganism effect
PH12016501448A1 (en) Antifungal composition
CL2011002963A1 (es) Composicion para controlar enfermedades de plantas que comprende acido 4-oxo-4-[(2-feniletilamino]-butirico y ethaboxam; agente de tratamiento de semillas; y uso.
AR111032A1 (es) Composición líquida que contiene pradofloxacina
CL2014002401A1 (es) Composicion de accion prolongada que incluye un agente bioactivo, un portador no acuoso, aceite de ricino y al menos una amida ciclica; metodo de preparacion; uso para prevenir o tratar una infeccion parasitaria en un animal.
UY34895A (es) Formulaciones estabilizadas de etanercept

Legal Events

Date Code Title Description
FC Refusal